BCM
DXCM icon

Brooktree Capital Management’s DexCom DXCM Stock Holding History

Brooktree Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.16M Buy
50,278
+5,621
+13% +$391K 2.5% 12
2025
Q4 		$2.96M Buy
44,657
+2,777
+7% +$180K 1.97% 12
2025
Q3 		$2.82M Buy
41,880
+12,635
+43% +$1,000K 1.79% 14
2025
Q2 		$2.55M Buy
29,245
+13,713
+88% +$1.07M 1.67% 13
2025
Q1 		$1.06M Buy
15,532
+1,896
+14% +$155K 0.8% 20
2024
Q4 		$1.06M Buy
13,636
+3,453
+34% +$256K 0.79% 20
2024
Q3 		$683K Buy
+10,183
New +$836K 0.55% 22

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brooktree Capital Management's DXCM Position: Q1 2026 in Review

Brooktree Capital Management increased its DexCom (DXCM) stake by 13% in Q1 2026, buying an estimated $391K and bringing the position to 50,278 shares worth $3.16M. The position accounts for 2.5% of the portfolio, ranked #12.

Brooktree Capital Management first reported a position in DXCM in Q3 2024 and has held it in 7 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Brooktree Capital Management held 50,278 shares of DexCom worth $3.16M as of Q1 2026.
  • Brooktree Capital Management bought 5,621 DexCom shares in Q1 2026, an estimated $391K.
  • DexCom made up 2.5% of Brooktree Capital Management's portfolio in Q1 2026, its #12 holding.
  • Brooktree Capital Management first reported a position in DexCom in Q3 2024 and has held it in 7 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Brooktree Capital Management's 13F filing for Q1 2026, filed 6 May 2026.